dc.contributor.author |
Gergely András |
|
dc.contributor.author |
Zsila Ferenc |
|
dc.contributor.author |
Horváth Péter |
|
dc.contributor.author |
Szász György |
|
dc.date.accessioned |
2018-07-30T15:06:31Z |
|
dc.date.available |
2018-07-30T15:06:31Z |
|
dc.date.issued |
1999 |
|
dc.identifier.citation |
pagination=741-744;
journalVolume=11;
journalIssueNumber=10;
journalTitle=CHIRALITY: THE PHARMACOLOGICAL BIOLOGICAL AND CHEMICAL CONSEQUENCES OF MOLECULAR ASYMMETRY; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/5469 |
|
dc.identifier.uri |
doi:10.1002/(SICI)1520-636X(1999)11:10<741::AID-CHIR1>3.0.CO;2-2 |
|
dc.description.abstract |
Recognizing that the stereochemical structure of NMDA receptor antagonist ketamine provides valuable data about the relationship between its conformation and absolute configuration by CD-UV analysis, a method for the identification of ketamine enantiomers is proposed which avoids the need for authentic samples of the enantiomers. The ketamine enantiomers were separated by HPLC using Chiralcel OJ stationary phase. The in situ registration of CD and UV spectra, together with the application of the octant rule for cyclohexanone derivatives, makes possible the direct assignment of the eluted ketamine enantiomers. |
|
dc.relation.ispartof |
urn:issn:0899-0042 |
|
dc.title |
Determination of absolute configuration of ketamine enantiomers by HPLC-CD-UV technique |
|
dc.type |
Journal Article |
|
dc.date.updated |
2018-05-28T07:02:49Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
1071385 |
|
dc.identifier.wos |
000083656000001 |
|
dc.identifier.pubmed |
10561702 |
|
dc.contributor.department |
SE/GYTK/Gyógyszerészi Kémiai Intézet |
|
dc.contributor.institution |
Semmelweis Egyetem |
|